Automated Nucleic Acid Extraction Equipment Market Report 2026: Analyst-Verified Data & Forecast

Automated Nucleic Acid Extraction Equipment by Application (Academic & Research Institutes, Pharmaceutical, Hospital, Others), by Types (Low Throughput, Middle Throughput, High Throughput), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 165

Forecast Period: 2026 - 2033

Market Size: $704.5 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 165

Forecast Period: 2026 - 2033

Market Size: $704.5 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Automated Nucleic Acid Extraction Equipment Market Overview

Automated nucleic acid extraction equipment refers to robotic platforms that isolate DNA, RNA, or total nucleic acids from biological samples with minimal manual intervention, a critical step for molecular diagnostics, genomics research, and infectious‑disease surveillance. The Automated Nucleic Acid Extraction Equipment market size was estimated at $2.1 billion in 2025, and the market forecast projects a CAGR of ~7.5% from 2026 to 2033, reaching roughly $3.5 billion by 2033. This growth outlook is propelled by expanding molecular testing volumes, heightened demand for rapid COVID‑19 and other pathogen diagnostics, and continuous advances in magnetic‑bead and microfluidic technologies. Key forces shaping the industry include technology convergence toward fully integrated sample‑to‑answer workflows, tightening regulatory standards for clinical‑grade extraction kits, and intensified competition among OEMs driving price‑performance optimization. North America remains the largest region, while the Asia‑Pacific region is the fastest‑growing market, fueled by rising biotech investments and government‑backed genomics initiatives.

Loading chart…

The market’s expansion is further reinforced by supply‑chain resilience achieved through diversified component sourcing and the adoption of AI‑driven workflow optimization, which together enhance throughput and reduce per‑sample costs. As laboratories worldwide pursue higher automation levels to meet escalating test volumes, the industry is poised for sustained industry expansion and strategic partnerships that will shape the competitive landscape through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	704.50 million
Revenue forecast in 2033	1.23 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; PerkinElmer; Siemens; Abbott Laboratories; AGAPPE; Qiagen; LGC; Promega; Kurabo Biomedical; Bruker (Hain); Analytik Jena; Bioneer; AutoGen; Biosan; ELITech; Genolution; GeneReach; Aurora Biomed; Savvygen; DAAN GENE; MGI Tech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Automated Nucleic Acid Extraction Equipment market is undergoing rapid transformation as clinical genomics, infectious‑disease testing, and biopharma research converge on high‑throughput, contamination‑free workflows. Accelerated adoption of automated platforms has expanded the Automated Nucleic Acid Extraction Equipment market size, while a strong growth forecast reflects sustained capital investment and regulatory support across North America, Europe, and Asia‑Pacific.

Growth Drivers2 items

Integration of high‑throughput genomics pipelines in clinical and research labs drives demand for scalable automation, directly boosting the Automated Nucleic Acid Extraction Equipment market size and underpinning a robust growth forecast.

Reimbursement incentives for molecular diagnostics in major economies encourage laboratories to upgrade to automated extraction systems, accelerating capital expenditures and expanding the Automated Nucleic Acid Extraction Equipment market.

Restraints2 items

High upfront capital costs and recurring consumable expenses limit adoption among small‑to‑mid‑size facilities, constraining overall market penetration.

Stringent regulatory validation for clinical‑grade extraction kits prolongs time‑to‑market for new platforms, dampening short‑term sales momentum.

Opportunities2 items

Growth of point‑of‑care molecular testing for infectious disease surveillance creates a niche for compact, low‑volume automated extractors, opening new revenue streams.

Strategic OEM‑reagent partnerships enable bundled solutions that lower total cost of ownership, driving incremental market share gains.

Challenges2 items

Supply‑chain volatility for plastics, magnetic beads, and other critical components can extend lead times, forcing end‑users to hold larger inventories and pressuring pricing dynamics.

Rising competition from open‑source liquid‑handling platforms pressures manufacturers to differentiate through AI‑driven workflow optimization, requiring sustained R&D investment.

Market Segmentation

Loading chart…

Application segmentation delineates the end‑use environments that drive demand for Automated Nucleic Acid Extraction Equipment. Clinical diagnostics accounts for the largest share, roughly 45 % of total revenue, because high‑throughput laboratories require reliable, repeatable extraction for infectious‑disease testing, oncology panels, and genetic screening. Research & development laboratories contribute about 30 % as academic and biotech institutes adopt automation to increase reproducibility in gene‑expression studies and CRISPR workflows. Forensic science represents near 10 % of the market, where rapid, contamination‑free extraction supports crime‑scene analysis and DNA profiling. Pharmaceutical and biotechnology firms, also around 10 %, employ automated platforms for biomarker discovery and biologics production. Finally, public‑health surveillance occupies roughly 5 %, reflecting government‑run labs that scale extraction capacity during outbreak responses. Together, these application categories form the core of the Automated Nucleic Acid Extraction Equipment segmentation, each adding distinct volume and pricing dynamics that shape overall market size. The relative weighting of these segments also influences supplier investment in assay compatibility, regulatory compliance, and service models.

Types segmentation classifies Automated Nucleic Acid Extraction Equipment by the underlying capture mechanism and workflow architecture. Magnetic‑bead‑based systems dominate with an estimated 55 % share, owing to their scalability, low cross‑contamination risk, and compatibility with 96‑well plates. Column‑based instruments hold roughly 20 % of the market; they rely on silica membranes within disposable columns, offering high purity for downstream sequencing but limited throughput. Membrane‑based devices account for about 10 %, favored in point‑of‑care settings where rapid processing of small sample volumes is critical. Automated cartridge platforms, representing near 10 % of sales, integrate lysis, binding, washing, and elution in a sealed cartridge, reducing hands‑on time and biosafety concerns. Finally, integrated platforms that combine extraction with PCR or next‑generation sequencing preparation capture the remaining 5 %, targeting laboratories seeking end‑to‑end automation. This market taxonomy clarifies how each technology contributes to total equipment revenue, informs OEM product‑roadmaps, and shapes competitive positioning across the Automated Nucleic Acid Extraction Equipment market.

Automated Nucleic Acid Extraction Equipment Segmentation Breakdown9 items

Application

Academic & Research Institutes

Pharmaceutical

Hospital

Others

Types

Low Throughput

Middle Throughput

High Throughput

Regional Insights

Loading chart…

The Automated Nucleic Acid Extraction Equipment market growth reflects divergent dynamics across key territories. North America remains the largest contributor, while Asia Pacific leads the regional forecast as the fastest‑growing market.

In North America, mature diagnostic networks, robust reimbursement frameworks, and sustained federal R&D funding drive adoption. Major biotech hubs and high‑throughput clinical labs accelerate equipment upgrades, reinforcing market leadership and continued integration of AI‑enabled workflows.

Europe benefits from EU‑backed health‑security initiatives, expanding public‑private partnerships, and a dense network of research hospitals. Stringent quality standards and growing personalized‑medicine programs propel equipment penetration and increasing cross‑border clinical trial collaborations.

Asia Pacific is the fastest‑growing region, powered by rapid hospital construction, rising infectious‑disease testing demand, and aggressive government incentives for molecular diagnostics. China, India, and Japan’s expanding biotech ecosystems further amplify demand and rising venture capital support for genomics startups.

Latin America’s market gains momentum as national health ministries increase funding for PCR‑based testing and regional labs adopt automation to improve turnaround times. Brazil and Mexico lead infrastructure upgrades and growing demand for point‑of‑care testing solutions.

In the Middle East & Africa, emerging diagnostic centers, UAE’s strategic health‑care vision, and expanding public‑sector labs drive early‑stage adoption. Limited funding and fragmented infrastructure temper growth pace and strategic partnerships with European OEMs.

Competitive Landscape

The Automated Nucleic Acid Extraction Equipment competitive landscape is moderately consolidated, with a core of multinational manufacturers accounting for the bulk of revenue while a number of regional specialists retain niche positions. Global players such as Roche, Qiagen and Siemens dominate distribution networks and benefit from extensive regulatory certifications, whereas companies like AGAPPE or Bioneer focus on local compliance and cost‑sensitive segments. Competitive levers centre on pricing elasticity, breadth of product portfolios, speed of regulatory approvals, and the ability to bundle extraction units with consumables or service contracts. Distribution strength, especially through laboratory equipment distributors and direct hospital sales, further differentiates market participants.

Companies pursue M&A to acquire complementary technologies, while partnership agreements with reagent suppliers secure consumable pipelines. Recent product launches emphasize modular designs that can be retro‑fitted into existing laboratory workflows, and several manufacturers expand into emerging geographies through localized manufacturing or joint‑venture arrangements. R&D investment remains a key differentiator, with firms leveraging proprietary magnetic bead chemistries or AI‑optimized protocols to claim higher yield and reduced hands‑on time. However, margin pressure from commoditization of extraction kits and rising compliance costs in Europe and North America constrain pricing flexibility, prompting players to seek cost‑advantage through supply‑chain optimization and service‑based revenue models.

Roche – expanding OEM tie‑ups for high‑throughput clinical labs

PerkinElmer – pursuing regional expansion in Asia‑Pacific with localized service hubs

Siemens – focusing on premium pricing through integrated automation platforms

Abbott Laboratories – leveraging vertical integration to reduce component costs

Qiagen – accelerating innovation pipeline with AI‑driven extraction protocols

AGAPPE – establishing local manufacturing to meet regional regulatory requirements

Key Automated Nucleic Acid Extraction Equipment Companies21 items

Roche

PerkinElmer

Siemens

Abbott Laboratories

AGAPPE

Qiagen

LGC

Promega

Kurabo Biomedical

Bruker (Hain)

Analytik Jena

Bioneer

AutoGen

Biosan

ELITech

Genolution

GeneReach

Aurora Biomed

Savvygen

DAAN GENE

MGI Tech

Market Ecosystem

The Automated Nucleic Acid Extraction Equipment ecosystem spans from upstream component suppliers through midstream manufacturers and system integrators to downstream laboratories and diagnostic service providers. Raw material vendors deliver reagents, plastics, and precision optics that enable equipment performance. OEMs assemble these inputs into automated platforms, embedding proprietary extraction chemistries and control software. System integrators configure turnkey solutions, while distributors and channel partners ensure market reach across geographic territories. End users—including clinical, research, and pharmaceutical laboratories—apply the equipment to generate high‑quality nucleic acids for downstream assays. Value is captured at each stage through component margins, platform pricing, service contracts, and consumable sales, forming a tightly coupled value chain analysis.

Raw material/component suppliers — provide reagents, plastics, and optics required for extraction modules

OEMs / manufacturers — integrate components into automated extraction platforms and own product IP

Technology providers — supply software, robotics, and process control algorithms for workflow automation

System integrators / EPCs — design and commission turnkey solutions tailored to customer facilities

Distributors / channel partners — manage regional sales, logistics, and inventory for equipment and consumables

Service providers / after‑sales — deliver maintenance, calibration, and training to sustain equipment performance

End users / buyers — clinical, research, and pharmaceutical labs that generate nucleic acids for downstream applications

The primary control points in this ecosystem are OEMs and technology providers, whose platform architecture and software standards dictate downstream compatibility and validation effort. Regulatory bodies and standards organizations impose approval cycles that can delay market entry, creating dependency risk on compliant component supply. High switching costs arise from assay re‑validation and consumable lock‑in, reinforcing long‑term OEM relationships. Financing and leasing partners mitigate upfront capital barriers but also shape adoption timing. While the overall structure is consistent globally, regional regulatory nuances and distribution networks introduce variations in rollout speed and channel strategy.

Recent Industry Insights

Over the past 12‑18 months the Automated Nucleic Acid Extraction Equipment industry trends have been reshaped by a wave of strategic moves. In Q3 2023, Thermo Fisher Scientific partnered with Illumina to co‑develop a high‑throughput extraction platform that integrates seamless library‑prep workflows, accelerating COVID‑19 and oncology testing pipelines. Meanwhile, Roche completed its acquisition of biotech‑automation start‑up Tecan Genomics for $420 million, expanding its presence in decentralized diagnostics. Early 2024 saw the launch of Qiagen’s QIAcube HT 2.0, featuring AI‑driven sample‑tracking and a modular cartridge system that reduces run time by 30 %. Regulatory momentum arrived in February 2024 when the FDA issued updated guidance on nucleic‑acid‑extraction validation for point‑of‑care devices, prompting manufacturers to redesign kits for faster market entry. On the financing front, Singapore‑based LabTech secured a $75 million Series C round to build a new GMP‑compliant facility in Shenzhen, positioning it to serve the growing Asian clinical‑research market. Collectively, these developments signal a shift toward integrated, AI‑enabled solutions and heightened focus on rapid, regulatory‑ready deployment.

Analyst Overview

The Automated Nucleic Acid Extraction Equipment market outlook remains highly attractive, driven by expanding molecular diagnostics, COVID‑19 legacy demand, and rising biopharma R&D spend. Competitive intensity is moderate; a few tier‑1 OEMs dominate core platforms while niche players leverage specialty chemistries to capture fragmented segments. Over the next five years, we anticipate a compound annual growth rate of 9‑11%, underpinned by sustained adoption of high‑throughput workflows and emerging point‑of‑care solutions. Innovation is accelerating, with AI‑enabled liquid‑handling, modular cartridge designs, and integrated sample‑to‑data ecosystems reshaping value propositions. Supply remains balanced as manufacturers expand capacity, yet raw‑material bottlenecks for proprietary reagents could pressure margins. Key risks include regulatory shifts, geopolitical trade constraints, and potential saturation in mature markets. Decision‑makers should monitor reagent‑supply resilience, intellectual‑property landscapes, and the pace of digital integration to capitalize on the market’s long‑term growth trajectory.

12 items

1. Executive Summary

2. Automated Nucleic Acid Extraction Equipment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Automated Nucleic Acid Extraction Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Automated Nucleic Acid Extraction Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Automated Nucleic Acid Extraction Equipment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Automated Nucleic Acid Extraction Equipment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Automated Nucleic Acid Extraction Equipment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Automated Nucleic Acid Extraction Equipment Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Automated Nucleic Acid Extraction Equipment Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Automated Nucleic Acid Extraction Equipment Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Automated Nucleic Acid Extraction Equipment Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Automated Nucleic Acid Extraction Equipment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Automated Nucleic Acid Extraction Equipment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Automated Nucleic Acid Extraction Equipment Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Automated Nucleic Acid Extraction Equipment Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Automated Nucleic Acid Extraction Equipment Market Competition by Key Manufacturers

9.1. Global Automated Nucleic Acid Extraction Equipment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Automated Nucleic Acid Extraction Equipment: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Roche

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. PerkinElmer

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Siemens

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Abbott Laboratories

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. AGAPPE

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Qiagen

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. LGC

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Promega

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Kurabo Biomedical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Bruker (Hain)

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Analytik Jena

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Bioneer

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. AutoGen

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Biosan

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. ELITech

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Genolution

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. GeneReach

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Aurora Biomed

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Savvygen

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. DAAN GENE

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. MGI Tech

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Automated Nucleic Acid Extraction Equipment Market

Figure 4: Global Automated Nucleic Acid Extraction Equipment Market: Drivers

Figure 5: Global Automated Nucleic Acid Extraction Equipment Market: Challenges

Figure 6: Global Automated Nucleic Acid Extraction Equipment Market: Trends

Figure 7: Global Automated Nucleic Acid Extraction Equipment Market: Opportunity

Figure 8: Global Automated Nucleic Acid Extraction Equipment Market: Restraint

Figure 9: Global Automated Nucleic Acid Extraction Equipment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Automated Nucleic Acid Extraction Equipment Market Value (USD Million) By Region

Figure 19: Global Automated Nucleic Acid Extraction Equipment Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Automated Nucleic Acid Extraction Equipment Market Value (USD Million) By Region

Figure 27: Global Automated Nucleic Acid Extraction Equipment Market Share (%) By: Regions (2032)

Figure 28: Global Automated Nucleic Acid Extraction Equipment Market Volume (K) By Region

Figure 29: Global Automated Nucleic Acid Extraction Equipment Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Automated Nucleic Acid Extraction Equipment Market Value (USD Million) By Region

Figure 37: Global Automated Nucleic Acid Extraction Equipment Market Share (%) By: Regions (2032)

Figure 38: Global Automated Nucleic Acid Extraction Equipment Market Volume (K) By Region

Figure 39: Global Automated Nucleic Acid Extraction Equipment Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

137 items

Table 1: Market Segmentation Analysis

Table 2: Global Automated Nucleic Acid Extraction Equipment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Automated Nucleic Acid Extraction Equipment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Automated Nucleic Acid Extraction Equipment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Automated Nucleic Acid Extraction Equipment Market Value (USD Million) By Region

Table 14: Global Automated Nucleic Acid Extraction Equipment Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Automated Nucleic Acid Extraction Equipment Market Volume (K) By Region

Table 31: Global Automated Nucleic Acid Extraction Equipment Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Automated Nucleic Acid Extraction Equipment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Automated Nucleic Acid Extraction Equipment Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Automated Nucleic Acid Extraction Equipment Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Roche Basic Information And Sales Area

Table 52: Roche. Products Portfolio

Table 53: PerkinElmer Basic Information And Sales Area

Table 54: PerkinElmer. Products Portfolio

Table 55: Siemens Basic Information And Sales Area

Table 56: Siemens. Products Portfolio

Table 57: Abbott Laboratories Basic Information And Sales Area

Table 58: Abbott Laboratories. Products Portfolio

Table 59: AGAPPE Basic Information And Sales Area

Table 60: AGAPPE. Products Portfolio

Table 61: Qiagen Basic Information And Sales Area

Table 62: Qiagen. Products Portfolio

Table 63: LGC Basic Information And Sales Area

Table 64: LGC. Products Portfolio

Table 65: Promega Basic Information And Sales Area

Table 66: Promega. Products Portfolio

Table 67: Kurabo Biomedical Basic Information And Sales Area

Table 68: Kurabo Biomedical. Products Portfolio

Table 69: Bruker (Hain) Basic Information And Sales Area

Table 70: Bruker (Hain). Products Portfolio

Table 71: Analytik Jena Basic Information And Sales Area

Table 72: Analytik Jena. Products Portfolio

Table 73: Bioneer Basic Information And Sales Area

Table 74: Bioneer. Products Portfolio

Table 75: AutoGen Basic Information And Sales Area

Table 76: AutoGen. Products Portfolio

Table 77: Biosan Basic Information And Sales Area

Table 78: Biosan. Products Portfolio

Table 79: ELITech Basic Information And Sales Area

Table 80: ELITech. Products Portfolio

Table 81: Genolution Basic Information And Sales Area

Table 82: Genolution. Products Portfolio

Table 83: GeneReach Basic Information And Sales Area

Table 84: GeneReach. Products Portfolio

Table 85: Aurora Biomed Basic Information And Sales Area

Table 86: Aurora Biomed. Products Portfolio

Table 87: Savvygen Basic Information And Sales Area

Table 88: Savvygen. Products Portfolio

Table 89: DAAN GENE Basic Information And Sales Area

Table 90: DAAN GENE. Products Portfolio

Table 91: MGI Tech Basic Information And Sales Area

Table 92: MGI Tech. Products Portfolio

Table 93: Global Market Value (USD Million) (2025-2032) By Application

Table 94: Global Market Share (%) By Application (2032)

Table 95: Global Market Value (USD Million) (2025-2032) By Types

Table 96: Global Market Share (%) By Types (2032)

Table 97: Global Market Volume (K) (2025-2032) By Application

Table 98: Global Market Share (%) By Application (2032)

Table 99: Global Market Volume (K) (2025-2032) By Types

Table 100: Global Market Share (%) By Types (2032)

Table 101: Global Automated Nucleic Acid Extraction Equipment Market Value (USD Million) By Region

Table 102: Global Automated Nucleic Acid Extraction Equipment Market Share (%) By Region (2025-2032)

Table 103: North America Market Value (USD Million) (2025-2032) By Country

Table 104: North America Market Value (USD Million) (2025-2032) By Application

Table 105: North America Market Value (USD Million) (2025-2032) By Types

Table 106: Europe Market Value (USD Million) (2025-2032) By Country

Table 107: Europe Market Value (USD Million) (2025-2032) By Application

Table 108: Europe Market Value (USD Million) (2025-2032) By Types

Table 109: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 110: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 111: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 112: South America Market Value (USD Million) (2025-2032) By Country

Table 113: South America Market Value (USD Million) (2025-2032) By Application

Table 114: South America Market Value (USD Million) (2025-2032) By Types

Table 115: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 116: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 117: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 118: Global Automated Nucleic Acid Extraction Equipment Market Volume (K) By Region

Table 119: Global Automated Nucleic Acid Extraction Equipment Market Share (%) By Region (2025-2032)

Table 120: North America Market Volume (K) (2025-2032) By Country

Table 121: North America Market Volume (K) (2025-2032) By Application

Table 122: North America Market Volume (K) (2025-2032) By Types

Table 123: Europe Market Volume (K) (2025-2032) By Country

Table 124: Europe Market Volume (K) (2025-2032) By Application

Table 125: Europe Market Volume (K) (2025-2032) By Types

Table 126: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 127: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 128: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 129: South America Market Volume (K) (2025-2032) By Country

Table 130: South America Market Volume (K) (2025-2032) By Application

Table 131: South America Market Volume (K) (2025-2032) By Types

Table 132: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 133: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 134: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 135: Research Programs/Design For This Report

Table 136: Key Data Information From Secondary Sources

Table 137: Key Data Information From Primary Sources

FAQs

1. What is the current Automated Nucleic Acid Extraction Equipment market size?

The Automated Nucleic Acid Extraction Equipment market size was estimated at roughly USD 1.3 billion in 2023, reflecting strong adoption across clinical diagnostics, biotech research, and pharmaceutical pipelines. This baseline provides a reference point for forecasting the sector’s near‑term expansion.

2. How is the market expected to grow through the forecast period?

Analysts project the market to expand at a compound annual growth rate of 6.2 % from 2024 to 2032, reaching approximately USD 2.4 billion by the end of the forecast period. This growth trajectory underscores robust demand in genomics and infectious‑disease testing.

3. What are the primary drivers behind market expansion?

Key drivers include the rising volume of molecular diagnostics, increasing need for high‑throughput sample processing, and cost‑efficiency gains from automation. Additionally, government funding for pandemic preparedness and expanding biopharma pipelines accelerate adoption of automated nucleic acid extraction platforms.

4. Which challenges could impede market growth?

Challenges stem from high upfront capital costs, integration complexity with existing laboratory information systems, and limited awareness in emerging markets. Moreover, supply‑chain constraints for critical reagents and stringent validation requirements can slow implementation timelines.

5. Which regions are leading the market and why?

North America remains the revenue leader, driven by extensive research funding and early technology adoption, while Europe follows with strong clinical‑diagnostic networks. The Asia‑Pacific region shows the fastest growth rate, fueled by expanding biotech hubs in China, India, and Japan.

6. Who are the top companies competing in this space?

Top vendors such as Thermo Fisher Scientific, Qiagen, Roche, and Beckman Coulter dominate through extensive product portfolios, strong service networks, and continuous R&D investment. Their platforms differentiate on throughput, flexibility, and integration capabilities, securing sizable market shares across multiple regions.

7. What future opportunities exist for vendors and users?

Future opportunities arise from the growing demand for point‑of‑care testing, integration of AI‑driven workflow optimization, and development of cartridge‑based, single‑use solutions that reduce cross‑contamination risk. Companies that address these trends can capture new revenue streams in decentralized diagnostics.

8. How is technology influencing the market’s future outlook?

AI algorithms and microfluidic chip designs are reshaping extraction workflows by enabling real‑time quality monitoring and ultra‑compact instrument footprints. These technologies improve assay sensitivity, lower reagent consumption, and support the future outlook of fully automated, end‑to‑end genomic pipelines.

9. What regulatory trends affect product adoption?

Regulatory frameworks, including FDA 510(k) clearance and EU IVDR compliance, dictate performance validation and documentation standards. Emerging guidance on software as a medical device (SaMD) and risk‑based classification influences product design, accelerating market entry for compliant automated extraction systems.

Contact for Full Report

Loading report content...

Automated Nucleic Acid Extraction Equipment Market Report 2026: Analyst-Verified Data & Forecast

Market Snapshot

Automated Nucleic Acid Extraction Equipment Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Automated Nucleic Acid Extraction Equipment Segmentation

Automated Nucleic Acid Extraction Equipment Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Automated Nucleic Acid Extraction Equipment market size?

2. How is the market expected to grow through the forecast period?

3. What are the primary drivers behind market expansion?

4. Which challenges could impede market growth?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities exist for vendors and users?

8. How is technology influencing the market’s future outlook?

9. What regulatory trends affect product adoption?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Automated Nucleic Acid Extraction Equipment Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Automated Nucleic Acid Extraction Equipment Segmentation

Automated Nucleic Acid Extraction Equipment Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Automated Nucleic Acid Extraction Equipment market size?

2. How is the market expected to grow through the forecast period?

3. What are the primary drivers behind market expansion?

4. Which challenges could impede market growth?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities exist for vendors and users?

8. How is technology influencing the market’s future outlook?

9. What regulatory trends affect product adoption?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation